Work

Figure 2 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer

Year: 2026

Type: other

Abstract: Pharmacotype of BTC organoids. A, Heatmap showing PARIS assay results for all targeted drugs tested in at least five organoid cultures. B, Heatmap showing PARIS assay results for all chemotherapeutic agents tested in at least one organoid culture. White rectangles indicate drugs that were not tested in that screen. Asterisks next to a patient number indicate that the drug screen failed some parameter of quality control but was still evaluable.

DOI: 10.1158/2767-9764.33395330

Authors: Annie Blair Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski, Robert L. Diaz, Lauren R. Appleyard, Shalini Pereira, Brady Bernard, Milind M. Javle, Gentry G. King, Adam Diehl, William Proctor Harris, Sameek Roychowdhury, Christopher J. Kemp, Carla Grandori

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7204815506

Cites:

Cited by:

Related to: 10